Cancer Biomarker Market Size & Share Analysis by Type and Region, Forecast Report, 2025

9th September 2021 – Global Cancer Biomarker Market is anticipated to reach USD 33.7 billion by 2025. Biomarkers imply the molecules or substances found in tissues, blood, or the other body fluid; which states the abnormal and normal condition of the body. The cancer biomarkers tests are conducted to detect mutated or normal genes responsible for cancer.

The factors that propel the growth of the cancer biomarker industry include advancements in omics technologies, prevalence of cancer, growth in R&D funding from private bodies and government, rising healthcare spending, and increasing demand for personalized medicine in cancer treatments. On the other hand, there are factors that may hamper the growth of the market including reimbursement issues, need for immediate processing, and high cost of diagnosis. Cancer Biomarker Market is anticipated to grow at a significant CAGR of 14.3% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Access Cancer Biomarker Market Report with TOC @ https://www.millioninsights.com/industry-reports/cancer-biomarker-market

Cancer biomarker industry may be explored by type, application, biomolecule type, and geography. The market may be explored by type as Lung cancer, Prostate cancer, Breast cancer, Colorectal cancer, Liver cancer, Cervical cancer, Others. The “Breast Cancer” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 owing to growing consciousness about initial testing and rising base of target populace.

The key applications that could be explored in the Cancer Biomarker Market include Personalized medicine, Diagnostics, Drug Discovery and Development, and Others. The “Diagnostics” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 due to growing development of biomarker-based oncology tests with high sensitivity and specificity. The cancer biomarker industry could be explored based on Biomolecules type as Epigenetic Biomarkers, Proteomic Biomarkers, Genetic Biomarkers, Metabolic Biomarkers, and Others. The “Genetic biomarkers” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 due to high-reliability rate, and extensive usage.

North America accounted for the major share of the cancer biomarker market size in 2016 and will continue to lead in the forecast period. The factors that could be ascribed to the growth include increasing demand for personalized medicine, growing government funding for development and discovery of biomarkers, growing use of biomarkers in Drug Discovery and growth by pharmaceutical industries in that country, and acceptance of innovative omics technologies for biomarker discovery.

Some of the key players that fuel the growth of the cancer biomarker industry comprise F-Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific Inc.; QIAGEN; Affymetrix Inc.; Agilent Technologies; Illumina, Inc.; Merck & Co. Inc.; Sino Biological Inc.; Hologic, Inc.; Dickinson and Company, and Becton. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Request a Sample Copy of Cancer Biomarker Market Report @ https://www.millioninsights.com/industry-reports/cancer-biomarker-market/request-sample

Comments

Post a Comment

Popular posts from this blog

CO2 Compressor Industry 2030 Overview, Global Industry Size, Price, Future Analysis

  The global CO2 compressor market size was estimated at USD 2.16 billion in 2024 and is anticipated to reach USD 3.34 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.9% between 2025 and 2030. This notable growth is attributed to multiple driving factors. One of the foremost contributors is the advancement in CO2 compressor technologies, which has resulted in the development of more efficient, compact, and durable systems. These improvements are particularly significant for applications where reliability and energy efficiency are critical, such as industrial refrigeration and process cooling. Another major factor fueling the growth of the market is the rising demand for energy-efficient refrigeration solutions. As global environmental regulations tighten and industries focus on reducing their carbon footprint, CO2-based systems are gaining popularity as sustainable alternatives to conventional hydrofluorocarbon (HFC)-based systems. The global ...
Read more

Botulinum Toxin Market Key Players, Supply and Consumption Demand Analysis to 2030

  The global botulinum toxin market size was valued at USD 11.1 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030. Botulinum toxin is a protein and neurotoxin produced by the bacterium clostridium botulinum. The toxin is a selective blocker of acetylcholine released from nerves, which blocks neural transmission from the nerves when injected into muscle. Botulinum toxin is one of the most exceptional substances encountered in medicine and science. The adoption of botulinum toxin in cosmetology has grown rapidly over the decade, and at present it is one of the most common and widely performed aesthetic procedures in the world. The increasing concern for aesthetic features in developed and developing regions has led to an increase in the number of cosmetic procedures. The availability of a variety of botulinum toxin products such as botox, xeomin, dysport, and others will accelerate the market growth. The increasing...
Read more

Cycling Wear Market Analysis by Application 2030

  The global cycling wear market was valued at USD 6.04 billion in 2024 and is anticipated to grow significantly, reaching USD 9.80 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 8.5% between 2025 and 2030. The surge in market size is largely attributed to a considerable increase in the number of individuals taking up cycling, especially in urban regions. This trend is driven by various factors, including rising health consciousness, increasing environmental concerns, and efforts to reduce traffic congestion. As urban populations become more health-aware and eco-conscious, many are adopting cycling as a regular form of exercise and as a sustainable mode of transportation. Urban development policies have also started to align with this behavioral shift by investing in better cycling infrastructure. Cities across the globe are implementing initiatives such as dedicated bicycle lanes, secure bike parking zones, and integrated cycling net...
Read more